Agilent Technologies, Inc. (NYSE:A) Given Average Rating of "Moderate Buy" by Brokerages – MarketBeat

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Agilent Technologies, Inc. (NYSE:A – Get Rating) has been given an average recommendation of “Moderate Buy” by the sixteen research firms that are currently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $157.00.
A has been the topic of a number of recent research reports. Robert W. Baird boosted their price objective on Agilent Technologies from $160.00 to $170.00 in a research note on Tuesday. SVB Leerink raised their price objective on shares of Agilent Technologies from $145.00 to $160.00 and gave the stock an “outperform” rating in a research report on Tuesday. Citigroup increased their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the company a “neutral” rating in a research note on Tuesday. StockNews.com initiated coverage on shares of Agilent Technologies in a report on Wednesday, October 12th. They set a “strong-buy” rating for the company. Finally, Bank of America boosted their price target on shares of Agilent Technologies from $148.00 to $155.00 and gave the company a “buy” rating in a research note on Wednesday, August 17th.

Insider Activity

In other news, VP Padraig Mcdonnell sold 2,506 shares of the stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $134.33, for a total transaction of $336,630.98. Following the transaction, the vice president now owns 15,320 shares of the company’s stock, valued at $2,057,935.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, SVP Michael Tang sold 3,600 shares of the stock in a transaction on Tuesday, November 1st. The stock was sold at an average price of $139.50, for a total value of $502,200.00. Following the completion of the transaction, the senior vice president now owns 43,280 shares of the company’s stock, valued at $6,037,560. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Padraig Mcdonnell sold 2,506 shares of the firm’s stock in a transaction that occurred on Thursday, September 8th. The shares were sold at an average price of $134.33, for a total transaction of $336,630.98. Following the transaction, the vice president now owns 15,320 shares in the company, valued at approximately $2,057,935.60. The disclosure for this sale can be found here. Insiders sold 174,326 shares of company stock worth $26,474,537 over the last ninety days.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of A. BlackRock Inc. grew its holdings in shares of Agilent Technologies by 1.9% during the 3rd quarter. BlackRock Inc. now owns 32,943,190 shares of the medical research company’s stock valued at $4,004,242,000 after acquiring an additional 629,153 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Agilent Technologies by 1.0% in the third quarter. Vanguard Group Inc. now owns 24,955,720 shares of the medical research company’s stock valued at $3,033,368,000 after acquiring an additional 257,455 shares during the period. Price T Rowe Associates Inc. MD grew its position in Agilent Technologies by 1.4% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 16,652,764 shares of the medical research company’s stock worth $1,977,848,000 after purchasing an additional 223,279 shares during the last quarter. State Street Corp grew its position in Agilent Technologies by 0.6% during the third quarter. State Street Corp now owns 13,152,295 shares of the medical research company’s stock worth $1,598,661,000 after buying an additional 73,495 shares in the last quarter. Finally, Wellington Management Group LLP grew its holdings in shares of Agilent Technologies by 18.5% during the 1st quarter. Wellington Management Group LLP now owns 10,826,141 shares of the medical research company’s stock worth $1,432,622,000 after purchasing an additional 1,691,006 shares in the last quarter.

Agilent Technologies Stock Up 1.0 %

Shares of A opened at $156.96 on Friday. The stock has a 50 day moving average price of $134.43 and a 200 day moving average price of $128.66. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.41 and a current ratio of 2.03. The stock has a market capitalization of $46.47 billion, a price-to-earnings ratio of 37.64, a PEG ratio of 2.75 and a beta of 1.06. Agilent Technologies has a one year low of $112.52 and a one year high of $162.62.
Agilent Technologies (NYSE:A – Get Rating) last released its earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.14. The business had revenue of $1.85 billion during the quarter, compared to analyst estimates of $1.76 billion. Agilent Technologies had a net margin of 18.31% and a return on equity of 30.31%. The company’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.21 earnings per share. Equities research analysts forecast that Agilent Technologies will post 5.64 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 25th. Shareholders of record on Tuesday, January 3rd will be issued a $0.225 dividend. This represents a $0.90 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date of this dividend is Friday, December 30th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.21. Agilent Technologies’s dividend payout ratio is currently 20.14%.

Agilent Technologies Company Profile

(Get Rating)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

See Also

• Get a free copy of the StockNews.com research report on Agilent Technologies (A)
• MarketBeat: Week in Review 11/21 – 11/25
• Is the 60/40 Portfolio Mix Still in Vogue?
• Institutional Support for Analog Devices Remains High 
• Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
• Microsoft Shares: Is it Time to Back Up the Truck?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilent Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Agilent Technologies wasn’t on the list.
While Agilent Technologies currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.

source